Trial Profile
An Open-Label, Comparative, Randomized, Prospective Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2023
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary) ; Antithymocyte globulin; Corticosteroids; Mycophenolate mofetil
- Indications Kidney-pancreas transplant rejection
- Focus Therapeutic Use
- 05 Feb 2020 Results published in the American Journal of Transplantation
- 08 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 21 May 2013 Results presented at the American Transplant Congress - 13th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.